Efficacy of Fentanyl Transdermal Patch in Impacted Mandibular Third Molar Surgery-A Comparative Study.
Analgesia
Fentanyl
Opioid analgesic
Pain
Third molar surgery
Journal
Journal of maxillofacial and oral surgery
ISSN: 0972-8279
Titre abrégé: J Maxillofac Oral Surg
Pays: India
ID NLM: 101538309
Informations de publication
Date de publication:
Sep 2023
Sep 2023
Historique:
received:
19
02
2021
accepted:
06
11
2022
pmc-release:
01
09
2024
medline:
3
8
2023
pubmed:
3
8
2023
entrez:
3
8
2023
Statut:
ppublish
Résumé
Removal of mandibular third molars surgically is one of the most frequently performed oral surgical procedures which are often accompanied with post-operative pain, swelling and trismus. Despite general progress in pain management, moderate to severe acute post-operative pain after removal of lower third molars remains a problem. Fentanyl is an extremely effective drug in the treatment of severe chronic pain such as cancer pain and post-operative pains which acts by increasing patient's tolerance to pain. Fentanyl Transdermal System (FTS) is a rectangular transdermal patch which contains high concentration of fentanyl, a potent short-acting Schedule II opiate. In this study the efficacy of transdermal fentanyl for management of post-operative pain after impacted mandibular 3rd molar surgery is evaluated. 20 patients within the age group of 18-40 years with asymptomatic impacted mandibular third molars were equally divided into 2 groups as group A & group B which underwent surgery in Local Anaesthesia. In every patient one side belonged to group A and other side belonged to group B. 50 μg FTS was applied in group A while placebo patch was applied in group B. Patients in group A performed significantly better than group B in terms of mean pain intensity scores assessed by VAS and VRS along with minimum need of post-operative rescue analgesics. It was found that FTS resulted in significantly better pain relief, longer pain-free intervals, and lesser post-operative analgesic consumption.
Identifiants
pubmed: 37534350
doi: 10.1007/s12663-022-01820-4
pii: 1820
pmc: PMC10390443
doi:
Types de publication
Journal Article
Langues
eng
Pagination
609-613Informations de copyright
© The Association of Oral and Maxillofacial Surgeons of India 2022. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
Références
Am J Health Syst Pharm. 2005 Jun 1;62(11):1171-6
pubmed: 15914877
Med Oral Patol Oral Cir Bucal. 2016 Sep 01;21(5):e621-5
pubmed: 27475691
JAMA. 2004 Mar 17;291(11):1333-41
pubmed: 15026400
J Oral Maxillofac Surg. 1998 Apr;56(4):447-53; discussion 453-4
pubmed: 9541344
Clin Ther. 2008 Mar;30(3):469-81
pubmed: 18405786